Estrella Immunopharma, Inc.
ESLA
$1.15
$0.021.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.93M | 1.38M | 1.63M | 1.32M | 421.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 229.80K | 292.70K | 396.90K | 163.90K | 522.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.16M | 1.68M | 2.02M | 1.48M | 944.30K |
|
|
|||||
| Total Current Assets | 2.16M | 1.68M | 2.02M | 1.48M | 944.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M |
| Total Assets | 3.66M | 3.18M | 3.52M | 2.98M | 2.44M |
|
|
|||||
| Total Accounts Payable | 14.90K | 554.80K | 5.60K | 8.20K | 14.00K |
| Total Accrued Expenses | 8.45M | 12.61M | 12.96M | 8.88M | 4.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 6.00K | 4.00K | 4.00K | 10.00K |
| Total Finance Division Other Current Liabilities | 466.70K | 375.30K | 385.40K | 187.90K | 3.30K |
| Total Other Current Liabilities | 466.70K | 375.30K | 385.40K | 187.90K | 3.30K |
| Total Current Liabilities | 8.93M | 13.54M | 13.36M | 9.08M | 4.28M |
|
|
|||||
| Total Current Liabilities | 8.93M | 13.54M | 13.36M | 9.08M | 4.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.93M | 13.54M | 13.36M | 9.08M | 4.28M |
|
|
|||||
| Common Stock & APIC | 34.61M | 27.22M | 27.14M | 26.08M | 24.80M |
| Retained Earnings | -39.28M | -36.99M | -36.38M | -31.58M | -26.03M |
| Treasury Stock & Other | -598.40K | -598.40K | -598.40K | -598.40K | -598.40K |
| Total Common Equity | -5.27M | -10.37M | -9.84M | -6.09M | -1.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.27M | -10.37M | -9.84M | -6.09M | -1.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.27M | -10.37M | -9.84M | -6.09M | -1.83M |
|
|
|||||